Filing Flows

Filing Flows › Humana (HUM) › Q3 2026

Humana (HUM) Q3 2026 earnings results (third quarter 2026)

10-Q filed Nov 6, 2026

Humana (HUM) reported revenue of $41.2B for the third quarter 2026 (Q3 2026), +26% from a year earlier and +0.7% from the quarter before. Operating margin was 0.2%, net earnings $161M (0.4% of revenue).

Revenue$41.2B
Year over year+26%
Quarter over quarter+0.7%
Operating margin0.2%
Net earnings$161M

Humana, Q3 2026: revenue $41.2B (+26% year over year), operating margin 0.2%, net earnings $161M, operating cash flow $2.2B. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$41.2B+0.7%+26%
Operating profit$75.0M-94%-81%
Net earnings$161M-77%-17%
Operating cash flow$2.2B+10%+123%
Free cash flow$2.0B+10%+142%

What changed

Revenue was $41.2B in Q3 2026, up 26% year over year and up 1% from the previous quarter.

Operating profit was $0.07B, a 0.2% margin (down 1.0 points year over year). Operating profit fell $0.33B even though revenue rose $8.5B versus Q3 2025, so costs grew faster than sales. Total costs grew 27% against revenue growth of 26%. The fastest-growing cost line was Other operating costs (+30%). Net earnings were $0.16B, down 17% year over year. The effective tax rate was 19.9%. Non-operating items added $0.13B, 63% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $2.2B (up 123% year over year), 1343% of net earnings. Non-cash charges added back $0.16B of depreciation and amortization and $0.07B of share-based compensation. Working capital and other items added $1.8B. Capital expenditures of $0.14B left free cash flow of $2.0B.

Questions

What was Humana's revenue in the third quarter 2026?

Humana (HUM) reported revenue of $41.2B for the third quarter 2026 (Q3 2026), +26% from a year earlier and +0.7% from the quarter before.

Was Humana profitable in the third quarter 2026?

Operating profit was $75.0M (0.2% of revenue) and net earnings $161M.

Open the interactive Sankey →

Source: Humana 10-Q on SEC EDGAR.